Rehan Verjee
Directeur/Membre du Conseil chez TYRA BIOSCIENCES, INC.
Fortune : - $ au 30/04/2024
Profil
Rehan Verjee currently works at Precede Biosciences, Inc., as President, Chief Executive Officer & Director, Massachusetts Biotechnology Council, as Director, and Tyra Biosciences, Inc., as Independent Director from 2021.
Mr. Verjee also formerly worked at EMD Serono Canada, Inc., as Managing Director, Merck KGaA, as Global Head-Innovative Medicine Franchises, EMD Serono, Inc., as President from 2018 to 2021, and Merck KGaA, as Chief Marketing & Strategy Officer-Healthcare.
Mr. Verjee received his graduate degree from the University of Oxford.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TYRA BIOSCIENCE, INC
-.--% | 26/03/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Rehan Verjee
| Sociétés | Poste | Début |
|---|---|---|
| TYRA BIOSCIENCES, INC. | Directeur/Membre du Conseil | 01/06/2021 |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Directeur/Membre du Conseil | - |
Precede Biosciences, Inc.
 Precede Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Precede Biosciences is a company that aims to improve success rates in drug development and clinical practice by breaking down the barriers to precision medicine. The company is based in Boston, MA. The company seeks to redefine what can be learned from a simple blood draw to better target medicines to the right patients. Precede Biosciences is revolutionizing precision medicine by revealing unprecedented insights into disease-defining biology from a simple blood test. The CEO of the company is Rehan Verjee. | Directeur Général | - |
Anciens postes connus de Rehan Verjee
| Sociétés | Poste | Fin |
|---|---|---|
| MERCK KGAA | Corporate Officer/Principal | 01/03/2021 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | President | 01/03/2021 |
| EMD Serono Canada, Inc. | Directeur Général | - |
Formation de Rehan Verjee
| University of Oxford | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MERCK KGAA | Health Technology |
| TYRA BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Commercial Services |
Precede Biosciences, Inc.
Precede Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Precede Biosciences is a company that aims to improve success rates in drug development and clinical practice by breaking down the barriers to precision medicine. The company is based in Boston, MA. The company seeks to redefine what can be learned from a simple blood draw to better target medicines to the right patients. Precede Biosciences is revolutionizing precision medicine by revealing unprecedented insights into disease-defining biology from a simple blood test. The CEO of the company is Rehan Verjee. | Commercial Services |
| EMD Serono Canada, Inc. |